Tag: Office of Policy Planning

Today the Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services (HHS) jointly issued a Request for Information to understand how the practices of two types of...

The Federal Trade Commission will host a virtual workshop, Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care, on March 5, 2024, to examine the role of private equity...

Today the Federal Trade Commission issued a comment in response to the National Institute of Standards and Technology’s (NIST) request for information on its Draft Interagency Guidance Framework for...

Today, the Federal Trade Commission (FTC) challenged more than 100 patents held by manufacturers of brand-name asthma inhalers, epinephrine autoinjectors, and other drug products as improperly or...

The Federal Trade Commission today issued a policy statement , supported by the U.S. Food and Drug Administration (FDA), warning pharmaceutical companies that make and sell brand-name drugs that they...

The Federal Trade Commission voted to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit mangers (PBMs) that no longer reflect current...

The Federal Trade Commission announced today the withdrawal of two antitrust policy statements related to enforcement in health care markets: Statements of Antitrust Enforcement Policy in Health Care...

Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, July 20, 2023. The open meeting will commence at 11am ET and...

The Federal Trade Commission has learned that the state of Maine recently enacted legislation repealing the state’s Hospital and Health Care Provider Cooperation Act , which allowed for certain...

As part of its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued a compulsory...

In a comment to North Carolina House Health Committee members, the Federal Trade Commission staff opposed a bill pending before the state legislature attempting to prevent antitrust authorities from...

As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issued compulsory...

The Federal Trade Commission extended the deadline for members of the public to comment in response to its Request for Information on franchise agreements and franchisor business practices, including...

The Federal Trade Commission requests comment on franchise agreements and franchisor business practices, including how franchisors may exert control over franchisees and their workers. In a franchise...